Research and development (R&D) Systems takes on Oncor's Sunrise amplification:
This article was originally published in Clinica
Executive Summary
As part of a strategy to employ an open architecture strategy for its Sunrise amplification detection system, Oncor has signed a non-exclusive licence with R&D Systems. Oncor is to supply its proprietary Sunrise Primer reagents for the detection of Cytokine mRNA.